Bile test could spot bile duct cancer without needle biopsy
NCT ID NCT06416397
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a protein test on bile fluid can accurately diagnose cholangiocarcinoma (bile duct cancer). Researchers will collect bile samples from 200 adults with bile duct narrowing during a routine scope procedure. They will compare the protein test results with standard tissue biopsy results to see if the bile test is a reliable alternative.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Bordeaux
RECRUITINGPessac, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Web tool aims to empower rare cancer patients in genomic choices
- Breath of life: new test could sniff out gut cancers before they spread
- New ultrasound technique could reveal hidden blood vessels in liver tumors
- Could conscious sedation replace general anesthesia for gallbladder drainage?
- Giving cancer patients a say in genetic results may boost knowledge and satisfaction